Researchers evaluated the immunogenicity of the MenACWY-TT vaccine against hypervirulent serogroup Y meningococcal strains in ...

Researchers conducted a network meta-analysis to compare the efficacy of various oral antibiotic monotherapies for ...

Dr William Schaffner discusses strategies clinicians can use to address vaccine hesitancy, fatigue, and misinformation.

Researchers evaluated household contact transmission risks and vaccination timing among children younger than 5 years.

Research presented at CHEST 2026 highlights the role of rapid antimicrobial testing and antibiotic stewardship in patients ...

Investigators evaluated HPV vaccine initiation at ages 9 to 10 years vs 11 to 12 years across pediatric practices in Colorado ...

Researchers evaluated the association between maternal COVID-19 infection during pregnancy and subsequent neurologic ...

Long COVID rates are elevated in patients with autoimmune rheumatic conditions, highlighting the need for targeted clinical monitoring. HealthDay News — Patients with autoimmune rheumatic diseases ...

Infectious disease experts Paul E Sax, MD and Cynthia L Sears, MD shared their thoughts on the most compelling trends and studies in infectious diseases at IDWeek 2026, held from October 21 to 24, in ...

The updated vaccines are expected to be available in pharmacies, hospitals, and clinics in the coming days. In May 2026, the FDA’s Vaccines and Related Biological Products Advisory Committee ...

The committee voted for separate MMR and varicella vaccines for the first dose in toddlers. The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) ...

The mRNA-based influenza vaccine is expected to be available in the coming weeks. The Food and Drug Administration (FDA) has approved mFlusiva ®, the first mRNA-based influenza vaccine, for adults ...